Aptevo Therapeutics Inc.APVONASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P15
Within normal range
vs 5Y Ago
-2.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -22.23% |
| Q2 2025 | 3.92% |
| Q1 2025 | -1.54% |
| Q4 2024 | -22.42% |
| Q3 2024 | 13.46% |
| Q2 2024 | 13.73% |
| Q1 2024 | -9.38% |
| Q4 2023 | 2.70% |
| Q3 2023 | 19.77% |
| Q2 2023 | -5.44% |
| Q1 2023 | -0.94% |
| Q4 2022 | 1.28% |
| Q3 2022 | -2.94% |
| Q2 2022 | -34.77% |
| Q1 2022 | -38.89% |
| Q4 2021 | 14.95% |
| Q3 2021 | 16.99% |
| Q2 2021 | 16.93% |
| Q1 2021 | -1.01% |
| Q4 2020 | -9.17% |
| Q3 2020 | 8.24% |
| Q2 2020 | 10.69% |
| Q1 2020 | 1.15% |
| Q4 2019 | 26.90% |
| Q3 2019 | 18.20% |
| Q2 2019 | -12.73% |
| Q1 2019 | 15.83% |
| Q4 2018 | -12.08% |
| Q3 2018 | 2.55% |
| Q2 2018 | 7.83% |
| Q1 2018 | 19.74% |
| Q4 2017 | -62.55% |
| Q3 2017 | 3.07% |
| Q2 2017 | -11.92% |
| Q1 2017 | 68.06% |
| Q4 2016 | 58.09% |
| Q3 2016 | -454.72% |
| Q2 2016 | 1.06% |
| Q1 2016 | 29.83% |
| Q4 2015 | -40.28% |